Found 9 matching trials
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) PHASE2 The purpose of this study was to determine the appropriate dosing regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045) PHASE4 The purpose of this study is to evaluate the safety and tolerability of a 3...
Show More Location
Phoenix Childrens Hospital ( Site 1101)
Learn More & Join Trial
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy. PHASE3 Compared With Fosaprepitant dimeglumine for Injection and Palonosetron Hydr...
Show More Location
Zhe jiangCancer Hospital
Learn More & Join Trial
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting PHASE2 This study is aimed to evaluate the efficacy and safety of Fosrolapitant an...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors PHASE3 To evaluate the efficacy and safety of HR20013 for injection for prevention...
Show More Location
Sun Yat-sen University Cancer Center Yuexiu Campus
Learn More & Join Trial
Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV. NA To evaluate the safety of Fosaprepitant Dimeglumine Injection for the preve...
Show More Location
The First Affiliated Hospital of Air Force Military Medical University
Learn More & Join Trial
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) PHASE1 This study will determine the appropriate dosing regimen of aprepitant and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) PHASE3 This study aims to demonstrate that, when given concomitantly with a 5-hydr...
Show More Location
Multiple Locations
Learn More & Join Trial
Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy PHASE2 This randomized phase II trial studies how well rolapitant hydrochloride wo...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial